Statistical experimental design based studies on placebo and mitoxantrone-loaded albumin microspheres

被引:16
作者
Luftensteiner, CP [1 ]
Viernstein, H [1 ]
机构
[1] Univ Vienna, Inst Pharmaceut Technol, A-1090 Vienna, Austria
基金
奥地利科学基金会;
关键词
albumin microspheres; mitoxantrone; particle size; drug content; drug release; experimental design;
D O I
10.1016/S0378-5173(98)00166-5
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
A new technique for the preparation of hydrophilic, nonaggregating placebo albumin microspheres was developed. The influence of albumin concentration, poloxamer concentration, pH of albumin solution, and dispersion energy on mean microsphere size was investigated using a central composite design. The microspheres exhibited mean particle sizes in the range from 15 to 69 mu m. Mitoxantrone-loaded microspheres were prepared by dissolving the drug in an albumin solution prior to dispersion in the coherent phase. Effects and interactions of four relevant process factors (type of dehydrating agent, amount of glutaraldehyde, amount of mitoxantrone, and stabilisation time) on drug incorporation and particle diameter were determined according to a factorial design. Microspheres with mitoxantrone content from 6.1 to 11.5% (w/w), drug entrapment efficiency from 58 to 91%, and mean particle sizes from 25 to 36 mu m were obtained. Variation of stabilisation time showed no influence on the response variables. Nonaggregating particles with a smooth surface and high drug entrapment efficiency were obtained using a mitoxantrone/albumin ratio of 1/10 (w/w). The drug content was increased by the application of butanol instead of acetone as the dehydrating solvent while simultaneously increasing the amount of glutaraldehyde. The drug release following first order kinetics was delayed by increasing the crosslinking degree. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:87 / 99
页数:13
相关论文
共 20 条
[1]
ALBUMIN MICROSPHERES FOR INTRA-ARTERIAL TUMOR TARGETING .1. PHARMACEUTICAL ASPECTS [J].
BURGER, JJ ;
TOMLINSON, E ;
MULDER, EMA ;
MCVIE, JG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 23 (03) :333-344
[2]
CONTROLLED DELIVERY OF TAXOL FROM MICROSPHERES COMPOSED OF A BLEND OF ETHYLENE-VINYL ACETATE COPOLYMER AND POLY (D,L-LACTIC ACID) [J].
BURT, HM ;
JACKSON, JK ;
BAINS, SK ;
LIGGINS, RT ;
OKTABA, AMC ;
ARSENAULT, AL ;
HUNTER, WL .
CANCER LETTERS, 1995, 88 (01) :73-79
[3]
CODDE JP, 1993, ANTICANCER RES, V13, P539
[4]
DALBY RN, 1993, ENCY PHARM TECHNOLOG, V7, P161
[5]
The development of a novel intraperitoneal tumor-seeding prophylactic [J].
Demetrick, JS ;
Liggins, RT ;
Machan, L ;
Davis, NL ;
Burt, HM ;
Hunter, WL .
AMERICAN JOURNAL OF SURGERY, 1997, 173 (05) :403-406
[6]
MITOXANTRONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN THE CHEMOTHERAPY OF CANCER [J].
FAULDS, D ;
BALFOUR, JA ;
CHRISP, P ;
LANGTRY, HD .
DRUGS, 1991, 41 (03) :400-449
[7]
GLUTARALDEHYDE - ITS PURITY AND STABILITY [J].
GILLETT, R ;
GULL, K .
HISTOCHEMIE, 1972, 30 (02) :162-+
[8]
ALBUMIN MICROSPHERES .1. PHYSICO-CHEMICAL CHARACTERISTICS [J].
GUPTA, PK ;
HUNG, CT .
JOURNAL OF MICROENCAPSULATION, 1989, 6 (04) :427-462
[9]
HAGIWARA A, 1993, ANTI-CANCER DRUG DES, V8, P463
[10]
A NEW METHOD FOR THE SYNTHESIS OF SMOOTH, ROUND, HYDROPHILIC PROTEIN MICROSPHERES USING LOW CONCENTRATIONS OF POLYMERIC DISPERSING AGENTS [J].
LATHA, MS ;
JAYAKRISHNAN, A .
JOURNAL OF MICROENCAPSULATION, 1995, 12 (01) :7-12